SBWire

The earthquake in Japan in March 2011 will have a significant bearing on the country's metals industry for years to come. In the short term, the disruption halted production at several copper and aluminium refineries. It is also set to hurt demand as the economy has now slipped back into recession. However, we expect demand and supply of metals to pick up as reconstruction efforts continue. Steel and aluminium are the two sectors most likely to benefit as much of Japan's infrastructure around the epicentre of the earthquake has been damaged.

Reasons to Get this ReportGlobal Market Direct's pharmaceuticals report, "Merrimack Pharmaceuticals, Inc. - Product Pipeline Review - 2012" provides data on the Merrimack Pharmaceuticals, Inc.'s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Reasons to Get this ReportGlobal Markets Direct's, 'Gliosarcoma - Pipeline Review, H1 2012', provides an overview of the Gliosarcoma therapeutic pipeline. This report provides information on the therapeutic development for Gliosarcoma, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Gliosarcoma. 'Gliosarcoma - Pipeline Review, H1 2012' is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

This report is the result of an extensive survey drawn from ICD Research's exclusive panel of leading mining industry executives. It analyzes the changing procurement behaviour and strategies of the companies in the mining industry. The report also identifies future growth of buyers and suppliers and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

Beer (retail) in Mexico by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2012. This market covers packaged extra strong, strong, standard, light and no alcohol beers. Market size is based on sales through all retail channels (off trade) including direct to consumer. Market size for Beer (retail) in Mexico is given in %, MXN, USD and litres with a minimum of five years' historical data. Market Forecast is provided for five years. Included with this snapshot is socio-economic data for Mexico. Population, Consumer Price Index (CPI), Gross Domestic Product (GDP), Exchange Rates.

This report is the result of an extensive survey drawn from Canadean's exclusive panel of leading packaging industry executives. It analyzes how business strategies and practices in the packaging industry are set to change in 2012-13. This report gives you access to the category-level supplier selection criteria, business challenges and investment opportunities for leading purchase decision makers. The report also identifies future growth of buyers and suppliers, M&A and e-procurement. This report not only grants access to the opinions and strategies of business decision makers and competitors, but also examines their actions surrounding business priorities. The report also provides access to information categorized by region, company type and size.

This report is the result of an extensive survey drawn from Canadean's exclusive panel of leading food and beverage industry executives. It analyzes the future business challenges in the food and beverage industry for 2012-13. This report gives you access to the category-level business challenges of leading purchase decision makers. The report also identifies future growth of buyers and suppliers. The report also provides access to information categorized by region, company type and size.

Reasons to Get this ReportGBI Research, leading business intelligence provider, has released its latest research report, entitled "Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities". It provides a comprehensive overview of the healthcare system, and the pricing and reimbursement processes in the top seven countries of the world, with a detailed analysis of the different regulatory mechanisms used in these countries. The report closely scrutinizes the major pharmaceutical changes and oncology-related pricing and reimbursement in these countries in the recent past and their impact in the near future. The countries analyzed in the report are the US, the top five European countries of the UK, France, Italy, Germany and Spain; and Japan.

GlobalData, the industry analysis specialist, has released its new report, "Healthcare, Regulatory and Reimbursement Landscape - South Korea". The report is an essential source of information and an analysis on the healthcare, regulatory and reimbursement landscape of South Korea. The report identifies the key trends in the healthcare market of South Korea. The report also provides insights on the demographic, regulatory, reimbursement landscape and healthcare infrastructure of South Korea. Most importantly, the report provides valuable insights on the trends and segmentation of pharmaceutical and medical devices market. This report is built using data and information sourced from proprietary databases, secondary research and in-house analysis by GlobalData's team of industry experts.

GlobalData's new report, "China Cardiovascular Devices Market Outlook to 2018 - Cardiac Rhythm Management, Interventional Cardiology, Peripheral Vascular Devices, Electrophysiology Prosthetic Heart Valves and Others" provides key market data on the China Cardiovascular Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within 10 market categories - Cardiac Assist Devices, Cardiac Rhythm Management, Cardiovascular Monitoring and Diagnostic Devices, Cardiovascular Prosthetic Devices, Cardiovascular Surgery, Electrophysiology, External Defibrillators, Interventional Cardiology, Peripheral Vascular Devices and Prosthetic Heart Valves. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This profile is the essential source for top-level energy industry data and information. The report provides an overview of each of the key sub-segments of the energy industry in Brazil. It details the market structure, regulatory environment, infrastructure and provides historical and forecasted statistics relating to the supply/demand balance for each of the key sub-segments. It also provides information relating to the crude oil assets (oil fields, refineries, pipelines and storage terminals) in Brazil. The report compares the investment environment in Brazil with other countries in the region. The profiles of the major companies operating in the crude oil sector in Brazil together with the latest news and deals are also included in the report.

Sales and the use of cotton wool/buds/pads were not influenced by new product launches, marketing campaigns or shifts in consumer trends at the end of the review period. Sales, both value and volume, shift slightly between years, with cotton wool/buds/pads remaining a less dynamic category within tissue and hygiene.

Expenditure on ear care products for minor annoyances remained discretionary in 2011 despite the ever-growing interest in good health. OTC products are usually limited to ear drops to loosen ear wax.

In 2011, adult mouth care achieved sales worth GBP35 million, an increase of 5% in current value terms from 2010. The category will remain fairly static over the forecast period, with marginal growth achieved by new products and innovations in a concentrated and flat market. The UK's expanding ageing population offers long-term growth prospects for adult mouth care as the elderly are more likely to suffer from mouth disease, for example dry mouth, increasing the demand for treatment.

Extended vacation: RV sales will recover slowly as more Americans hit retirement and the road

Back from the brink: The industry will rebound with the return of investment in building construction markets

Mounting pressure to reduce the cost of R&D and boost productivity has resulted in pharma companies undertaking radical strategies as the search for efficiency continues. With the ongoing patent cliff triggering a wave of patent expiries, pharmaceutical R&D is at a turning point.

"Indian Business Traveler Expenditure on Hotels in 2012: Survey Brief" is the result of an extensive multi-industry survey drawn from Timetric's exclusive panel of Indian business travelers. It contains in-depth analysis on Indian hotel accommodation and forecast on expenditure patterns. This report examines hotel visits and expenditure on hotel accommodation of Indian business travelers. Survey results have been presented and analyzed based on age and company turnover.

During the review period, the travel intermediaries market in France increased in 2011 when compared to 2007, at a CAGR of XX%. The distribution of travel products in France is mainly structured around travel agents, tour operators and online travel agencies. Most large international companies operating are exclusively wholesalers. However, there is little distinction between local wholesalers and retailers, as some wholesalers sell directly to end users, while some retailers sell their products to a number of retail customers on a wholesale basis. Travel products are distributed through the open market, with most of the major intermediaries having their own private networks and business-to-business booking engines.

France benefits from a diversified and dense transportation network. The road network is the dominant approach for land-based movements. In 2010, the French government released a draft plan called 'Avant-Projet au Schema National des Infrastructures de Transports' for transportation infrastructure investments over the next two decades. As part of the plan, the government plans to allocate EURXX billion (US$XX billion) for the project, of which nearly XX% (EURXX billion) will be allocated to high-speed rail, XX% to bus lines, subways and urban trams, XX% to ports and waterways and the remaining XX% to roads and airports.

This report is the result of Timetric's extensive market research covering the educational buildings construction industry in Argentina. It contains detailed historic and forecast market value data for the educational buildings construction industry, including a breakdown of the data by construction activity (new construction, repair and maintenance, refurbishment and demolition). 'Educational Building Construction in Argentina to 2016: Market Databook' provides a top-level overview and detailed insight into the operating environment of the educational buildings construction industry in Argentina. It is an essential tool for companies active across the Argentine construction value chain and for new players considering to enter the market.

Reasons to Get this ReportTEI Biosciences, Inc. (TEI Biosciences) is a biomedical company, based in the US. It develops and commercializes novel biological products for a broad spectrum of soft tissue repair and reinforcement applications. The company's products include durepair, primatrix, surgimend, surgimend PRS, tissuemend and xenform. Its products are also used for general surgery, neurosurgery, orthopedics, and urology and urogynecology applications. The company's products by clinical specialty are general surgery, neurosurgery, orthopedics, plastic and reconstructive surgery, urology and urogynecology and wound management. It is ISO 13485:2003 certified company. The company was incorporated in 1993. TEI Biosciences is headquartered in Boston, Massachusetts, the US.